Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma
Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test an experimental combination of drugs to
determine if they can cause shrinkage or even complete disappearance of your melanoma. The
two drugs being tested in combination are Rituxan and Abraxane
Phase:
Phase 2
Details
Lead Sponsor:
California Cancer Assocaties for Research & Excellence